Effect of ramipril on cardiovascular events in high-risk patients. Reply

被引：0
作者：
Yusuf, S [1 ]
机构：
[1] McMaster Univ, Hamilton, ON L8L 2X2, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [41] Carotid intima-media thickness and risk of cardiovascular events in high-risk patients
    Kitagawa, Kazuo
    Yamagami, Hiroshi
    Hashimoto, Hiroyuki
    Itoh, Taiji
    Shimizu, Yoshiomi
    Takahashi, Daisuke
    Kondo, Kimito
    Hoshi, Taku
    Furukado, Shigetaka
    Abe, Yuko
    Sakaguchi, Manabu
    Hougaku, Hidetaka
    Matsumoto, Masayasu
    Hori, Masatsugu
    [J]. STROKE, 2007, 38 (02) : 522 - 522
  • [42] ONTARGET study of telmisartan, ramipril, or both in high-risk patients
    Ram, C. Venkata S.
    [J]. CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 345 - 348
  • [43] ONTARGET study of telmisartan, ramipril, or both in high-risk patients
    C. Venkata S. Ram
    [J]. Current Hypertension Reports, 2008, 10 : 345 - 348
  • [44] Effective prevention of cardiovascular events in high-risk patients - new indications for telmisartan
    Dziwura, Joanna
    Widecka, Krystyna
    [J]. ARTERIAL HYPERTENSION, 2010, 14 (04): : 332 - 343
  • [45] PCSK9 inhibition reduces cardiovascular events in high-risk patients
    Karina Huynh
    [J]. Nature Reviews Cardiology, 2017, 14 : 251 - 251
  • [46] Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients
    Reiter, Markus
    Effenberger, Isabella
    Sabeti, Schila
    Mlekusch, Wolfgang
    Schlager, Oliver
    Dick, Petra
    Puchner, Stefan
    Amighi, Jasmin
    Bucek, Robert A.
    Minar, Erich
    Schillinger, Martin
    [J]. RADIOLOGY, 2008, 248 (03) : 1050 - 1055
  • [47] The cardiovascular polypill in high-risk patients
    Lafeber, Melvin
    Spiering, Wilko
    Singh, Kavita
    Guggilla, Rama K.
    Patil, Vinodvenkatesh
    Webster, Ruth
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) : 1234 - 1242
  • [48] Ramipril and telmisartan: Equally effective for patients at high risk of vascular events?
    不详
    [J]. JOURNAL OF FAMILY PRACTICE, 2008, 57 (07) : 443 - 443
  • [49] Prophylaxis of cytomegalovirus disease in high-risk patients.
    Scholz, M
    Cinatl, J
    Doerr, W
    [J]. INFECTION, 1997, 25 (05) : 269 - 273
  • [50] Safety of cidofovir in high-risk paediatric patients.
    Bhadri, Vivek A.
    Lee-Horn, Lisa
    Shaw, Peter J.
    [J]. BLOOD, 2006, 108 (11) : 416B - 416B
12345